Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Equity Average (2016 - 2020)

Glucotrack's Equity Average history spans 7 years, with the latest figure at $10.2 million for Q3 2020.

  • For the quarter ending Q3 2020, Equity Average rose 2503.4% year-over-year to $10.2 million, compared with a TTM value of $10.2 million through Sep 2020, up 2503.4%, and an annual FY2019 reading of -$2.1 million, up 77.97% over the prior year.
  • Equity Average for Q3 2020 was $10.2 million at Glucotrack, down from $10.7 million in the prior quarter.
  • The five-year high for Equity Average was $10.7 million in Q2 2020, with the low at -$16.6 million in Q2 2018.
  • Average Equity Average over 5 years is -$6.5 million, with a median of -$9.9 million recorded in 2016.
  • Year-over-year, Equity Average plummeted 65.47% in 2016 and then skyrocketed 2503.4% in 2020.
  • Tracing GCTK's Equity Average over 5 years: stood at -$10.4 million in 2016, then crashed by 50.42% to -$15.7 million in 2017, then soared by 39.94% to -$9.4 million in 2018, then skyrocketed by 87.94% to -$1.1 million in 2019, then surged by 995.37% to $10.2 million in 2020.
  • Per Business Quant, the three most recent readings for GCTK's Equity Average are $10.2 million (Q3 2020), $10.7 million (Q2 2020), and $4.8 million (Q1 2020).